Skip to main content
. 2010 Jun 19;59(10):1521–1530. doi: 10.1007/s00262-010-0879-0

Fig. 1.

Fig. 1

Study population and escalating dose. A total of 28 patients were treated in this study, 22 in the dose-escalation phase up to a dose level of 1,800 mg/m2. An amendment was introduced at the end of the first part of the escalating dose to have IL2 administered from cycle 1 at a dose level of 1,500 mg/m2